An advanced NSCLC patient with ALK-RNF144A and HIP1-ALK fusions treated with ALK-TKI combination therapy: a case report

An advanced NSCLC patient with ALK-RNF144A and HIP1-ALK fusions treated with ALK-TKI combination therapy: a case report

Saved in:
Bibliographic Details
Main Authors: Li, Hui (Author) , Liu, Jingjing (Author) , Lan, Shaowei (Author) , Zhong, Rui (Author) , Cui, Yanan (Author) , Christopoulos, Petros (Author) , Schenk, Erin L. (Author) , Sasaki, Takaaki (Author) , Cheng, Ying (Author)
Format: Article (Journal)
Language:English
Published: Nov 24, 2023
In: Translational Lung Cancer Research
Year: 2023, Volume: 12, Issue: 12, Pages: 2538-2549
ISSN:2226-4477
DOI:10.21037/tlcr-23-656
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.21037/tlcr-23-656
Verlag, lizenzpflichtig, Volltext: https://tlcr.amegroups.org/article/view/80743
Get full text
Author Notes:Hui Li, Jingjing Liu, Shaowei Lan, Rui Zhong, Yanan Cui, Petros Christopoulos, Erin L. Schenk, Takaaki Sasaki, Ying Cheng
Description
Summary:An advanced NSCLC patient with ALK-RNF144A and HIP1-ALK fusions treated with ALK-TKI combination therapy: a case report
Item Description:Gesehen am 18.01.2024
Physical Description:Online Resource
ISSN:2226-4477
DOI:10.21037/tlcr-23-656